Global News Aggregator
Strong second-quarter results from Moderna make now an opportune time to buy shares of the biotechnology company, Deutsche Bank said. Analyst Emmanuel Papadakis upgraded shares of the Covid-19 vaccine maker…
It’s a new milestone in the Covid-19 pandemic. People will soon roll up their sleeves and get jabbed with a booster shot tailored to the dominant coronavirus strain circulating in…
The U.S. authorized the first major makeover of the Covid-19 vaccines this week in an effort to stem an expected tide of infections and hospitalizations this fall. But it’s unclear…
Justin Sullivan | Getty Images The Centers for Disease Control and Prevention cleared reformulated Covid shots that target the latest omicron subvariants for the fall, making it possible for many…
People walk past a COVID-19 walk up testing site on July 28, 2022 in New York City. Liao Pan | China News Service | Getty Images Fall is on the…
In this photo illustration, vials and a medical syringe seen in front of the Food and Drug Administration (FDA) of the United States and Pfizer Pharmaceutical company logos. FDA approves…
A box of the Novavax Covid-19 vaccine arranged at a pharmacy in Schwenksville, Pennsylvania, US, on Monday, Aug. 1, 2022. Bloomberg | Bloomberg | Getty Images Biotechnology company Novavax announced…
Disney World celebrated its fiftieth anniversary in April 2022. Aaronp/bauer-griffin | Gc Images | Getty Images Check out the firms making headlines in noon buying and selling Monday. Poshmark —…
Britain has develop into the primary nation on the planet to approve Moderna’s bivalent Covid-19 vaccine, which objectives each the unique pressure of the virus and the more recent Omicron…
Bonds yields ticked downward on Monday, as traders digested the former week’s wave of information releases and wondered whether or not the U.S. Federal Reserve might gradual its tightening cycle…